AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28856403 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean intermittent catheterization (CIC)
Number of subjects: 85
Study 26333044 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary prevention using 800 mcg sublingual misoprostol administered to women with postpartum blood loss ≥350 ml
Number of subjects: 92
Study 26333044 — intervention group
Group type: COMPARATOR
Intervention: Universal prophylaxis using 600 mcg oral misoprostol administered to all women during the third stage of labour
Number of subjects: 92
Study 26333044 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary prevention
Number of subjects: 92
Study 26333044 — intervention group
Group type: COMPARATOR
Intervention: Primary prevention
Number of subjects: 92
Study 24937024 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical exercise (walking with strides) three times a week or more
Number of subjects: 157
Study 24937024 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued as normal)
Number of subjects: 157
Study 21951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Early infarct
Number of subjects: 173
Study 21951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Both early and late infarct
Number of subjects: 173
Study 21951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Late infarct only
Number of subjects: 173
Study 21951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of artery occlusion during surgery
Number of subjects: 173
Study 21951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission plasma glucose level
Number of subjects: 173
Study 21951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Amount of subarachnoid blood
Number of subjects: 173
Study 20451181 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin and clomiphene citrate
Number of subjects: 0
Study 20451181 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study 20451181 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 0
Study 19393260 — intervention group
Group type: EXPERIMENTAL
Intervention: Cues with negative Weber contrast between 6% and 100%
Number of subjects: 0
Study 19393260 — intervention group
Group type: EXPERIMENTAL
Intervention: High contrast motion stimuli
Number of subjects: 0
Study 15902892 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐RA with 180 degrees rotation
Number of subjects: 22
Study 15902892 — intervention group
Group type: COMPARATOR
Intervention: 3D‐RA with 160 degrees rotation and 1.4-mm catheter
Number of subjects: 22
Study 15902892 — intervention group
Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 22
Study 14694856 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric rehabilitation programmes for stroke patients (6 papers, 1138 patients)
Number of subjects: 9496
Study 14694856 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric rehabilitation for hip fractures (7 articles, 2414 patients)
Number of subjects: 9496
Study 14694856 — intervention group
Group type: COMPARATOR
Intervention: Geriatric rehabilitation in acute admissions (10 studies, 4683 patients)
Number of subjects: 9496
Study 14694856 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric programmes in nursing homes, day hospitals, and in-home services (7 studies, 1261 patients)
Number of subjects: 9496
Study 10329808 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray 0.14 mg per nostril twice daily
Number of subjects: 16
Study 10329808 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine tablets 10 mg every day
Number of subjects: 16
Study 10329808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8534682 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal equilibration test (PET) performed twice
Number of subjects: 19
Study 8534682 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal equilibration test (PET)
Number of subjects: 19
Study 1938800 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.4 mg/kg/day)
Number of subjects: 27
Study 1938800 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine (1.75 mg/kg/day)
Number of subjects: 27
Study 7049304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical doxorubicin (Adriamycin)
Number of subjects: 15
Study 7049304 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and urokinase
Number of subjects: 15
Study 7049304 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15
Study 31376167 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning before scaling and root planing (SRP)
Number of subjects: 52
Study 31376167 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) without professional tooth cleaning
Number of subjects: 52
Study 31376167 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning before SRP
Number of subjects: 52
Study 31376167 — intervention group
Group type: COMPARATOR
Intervention: Control group (no professional tooth cleaning)
Number of subjects: 52
Study 31376167 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 30277655 — intervention group
Group type: COMPARATOR
Intervention: GSK3179106 single-dose (10 mg to 800 mg)
Number of subjects: 62
Study 30277655 — intervention group
Group type: COMPARATOR
Intervention: GSK3179106 repeat-dose (5 mg to 100 mg QD and 100 mg to 200 mg BID for 14 days)
Number of subjects: 62
Study 30277655 — intervention group
Group type: COMPARATOR
Intervention: GSK3179106 (single doses up to 800 mg and repeat doses up to 400 mg)
Number of subjects: 62
Study 29241909 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine butyl-bromide (20 mg in 1 ml)
Number of subjects: 160
Study 29241909 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (1 ml)
Number of subjects: 160
Study 25695468 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion and Meaning Message
Number of subjects: 60
Study 25695468 — intervention group
Group type: EXPERIMENTAL
Intervention: Facts and Information Message
Number of subjects: 60
Study 24359041 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate plus oxytocin
Number of subjects: 100
Study 24359041 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate plus hCG
Number of subjects: 100
Study 21647560 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 with concurrent radiotherapy
Number of subjects: 50
Study 19647523 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback summary
Number of subjects: 61
Study 19647523 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 61
Study 18089875 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus gemcitabine/platinum (cisplatin or carboplatin)
Number of subjects: 131
Study 18089875 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (gemcitabine/platinum without cetuximab)
Number of subjects: 131
Study 16113546 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg
Number of subjects: 634
Study 16113546 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 634
Study 16113546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 634
Study 11966928 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional toothbrusher
Number of subjects: 24
Study 11966928 — intervention group
Group type: COMPARATOR
Intervention: Two brushes
Number of subjects: 24
Study 10464830 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled albuterol 0.2 mg four times daily
Number of subjects: 32
Study 10464830 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg four times daily
Number of subjects: 32
Study 7589374 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol 50 micrograms b.i.d.
Number of subjects: 120
Study 7589374 — intervention group
Group type: COMPARATOR
Intervention: Inhaled salbutamol 400 micrograms b.i.d.
Number of subjects: 120
Study 7589374 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Quality of Life Questionnaire (AQLQ)
Number of subjects: 120
Study 7589374 — intervention group
Group type: EXPERIMENTAL
Intervention: Living With Asthma Questionnaire (LWAQ)
Number of subjects: 120
Study 7589374 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness Impact Profile (SIP)
Number of subjects: 120
Study 7589374 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating Scale (RS)
Number of subjects: 120
Study 7589374 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Gamble (SG) utilities
Number of subjects: 120
Study 2304407 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at 4.8 kph
Number of subjects: 24
Study 2304407 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging at 9.6 kph
Number of subjects: 24
Study 2304407 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging at 9.6 kph, 10% grade
Number of subjects: 24
Study 6268269 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy and irradiation
Number of subjects: 70
Study 6268269 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 70
Study 6268269 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed chemotherapy following radiotherapy recurrence
Number of subjects: 70
Study 6268269 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy groups
Number of subjects: 70
Study 6268269 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study 6268269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of irradiation
Number of subjects: 70
Study 6268269 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate portals
Number of subjects: 70
Study 6268269 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate irradiation fields
Number of subjects: 70
Study 31449577 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform-switched implant
Number of subjects: 20
Study 31449577 — intervention group
Group type: COMPARATOR
Intervention: Platform-matched implant
Number of subjects: 20
Study 27956033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (application of a bag of crushed ice for 20 minutes)
Number of subjects: 50
Study 27956033 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 50
Study 27956033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 50
Study 25819187 — intervention group
Group type: EXPERIMENTAL
Intervention: Angio-guided provisional side-branch stenting
Number of subjects: 320
Study 25819187 — intervention group
Group type: COMPARATOR
Intervention: FFR-guided provisional side-branch stenting
Number of subjects: 320
Study 23721147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT) with simultaneous-integrated boost and weekly cisplatin 40 mg/m² (median 6 cycles)
Number of subjects: 45
Study 21855223 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute nicotine administration (placebo, low, or high dose nicotine patch)
Number of subjects: 86
Study 21855223 — intervention group
Group type: COMPARATOR
Intervention: Chronic smoking (cigarette smoking group)
Number of subjects: 86
Study 21855223 — intervention group
Group type: COMPARATOR
Intervention: Non-smoking controls (placebo or low dose)
Number of subjects: 86
Study 21855223 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute nicotine administration
Number of subjects: 86
Study 19151048 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (24 microg kg(‐1) administered as a slow i.v. bolus over 10 min)
Number of subjects: 106
Study 19151048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 17943675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive gait-oriented physiotherapy
Number of subjects: 22
Study 15475130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle brace worn on the supporting leg
Number of subjects: 10
Study 15475130 — intervention group
Group type: COMPARATOR
Intervention: No ankle brace
Number of subjects: 10
Study 10841002 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine[15]
Number of subjects: 24
Study 10841002 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine[80]
Number of subjects: 24
Study 10841002 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 24
Study 10841002 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine[30]
Number of subjects: 24
Study 10841002 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 24
Study 10174312 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiludronic acid (400 mg/day)
Number of subjects: 0
Study 10174312 — intervention group
Group type: COMPARATOR
Intervention: Etidronic acid
Number of subjects: 0
Study 1612505 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP5 (5 cycles of cyclophosphamide, doxorubicin, and cisplatin)
Number of subjects: 78
Study 1612505 — intervention group
Group type: COMPARATOR
Intervention: CAP10 (10 cycles of cyclophosphamide, doxorubicin, and cisplatin)
Number of subjects: 78
Study 1612505 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP5
Number of subjects: 78
Study 6584449 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1 g) daily for 180 days
Number of subjects: 66
Study 6584449 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets daily for 180 days
Number of subjects: 66
Study 31626654 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomus guggisbergi
Number of subjects: 729
Study 31626654 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomus saevus sensu lato
Number of subjects: 729
Study 31626654 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sandfly population
Number of subjects: 729
Study 31626654 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomus guggisbergi and Phlebotomus saevus sensu lato
Number of subjects: 729
Study 30041656 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (variety of games related to attention, memory, visual-spatial ability, and executive function)
Number of subjects: 600
Study 30041656 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 600
Study 25790761 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation
Number of subjects: 60
Study 1458768 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 9
Study 1458768 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,2‐GDN
Number of subjects: 9
Study 1458768 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,3‐GDN
Number of subjects: 9
Study 22697444 — intervention group
Group type: EXPERIMENTAL
Intervention: BA-TE in-person
Number of subjects: 40
Study 22697444 — intervention group
Group type: COMPARATOR
Intervention: BA-TE HBT
Number of subjects: 40
Study 20352355 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic dependence on a male partner
Number of subjects: 0
Study 20352355 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual assertiveness
Number of subjects: 0
Study 18684261 — intervention group
Group type: EXPERIMENTAL
Intervention: LV lead implanted at the lateral or posterolateral wall (group A)
Number of subjects: 77
Study 18684261 — intervention group
Group type: COMPARATOR
Intervention: LV lead implanted at the anterior or anterolateral wall (group B)
Number of subjects: 77
Study 18684261 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality in group A
Number of subjects: 77
Study 15816999 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program for preventive healthcare professionals in intervention municipalities.
Number of subjects: 4060
Study 15816999 — intervention group
Group type: COMPARATOR
Intervention: Control group with no education for healthcare professionals.
Number of subjects: 4060
Study 12891225 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg aprepitant on day 1 and then 80 mg/d on days 2 to 5
Number of subjects: 16
Study 12891225 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg aprepitant on day 1 and then 25 mg/d on days 2 to 5
Number of subjects: 16
Study 10374861 — intervention group
Group type: EXPERIMENTAL
Intervention: CML-type mRNA expression in CML patients
Number of subjects: 66
Study 10374861 — intervention group
Group type: EXPERIMENTAL
Intervention: ALL-type mRNA expression in CML patients
Number of subjects: 66
Study 10374861 — intervention group
Group type: EXPERIMENTAL
Intervention: BCR/ABL expression in ET, PV, MF, and CMML patients
Number of subjects: 66
Study 10374861 — intervention group
Group type: EXPERIMENTAL
Intervention: ALL-type chimeric mRNA expression
Number of subjects: 66
Study 8676115 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented total hip arthroplasty
Number of subjects: 147
Study 8676115 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless total hip arthroplasty
Number of subjects: 147
Study 8676115 — intervention group
Group type: COMPARATOR
Intervention: Control group (Cemented)
Number of subjects: 147
Study 8676115 — intervention group
Group type: COMPARATOR
Intervention: Control group (Cementless)
Number of subjects: 147
Study 2065470 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (n = 11) - graded walk‐jog programme to greater than 60% age‐predicted maximum heart rate, 45 min sessions, three times each week
Number of subjects: 19
Study 2065470 — intervention group
Group type: COMPARATOR
Intervention: Light intensity exercise (control group, n = 8) - flexibility (stretching exercises) and walking to less than 60% age‐predicted HRmax, 45 min sessions, three times each week
Number of subjects: 19
Study 525982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (three different doses)
Number of subjects: 42
Study 525982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 30870290 — intervention group
Group type: EXPERIMENTAL
Intervention: Force of stream
Number of subjects: 174
Study 30870290 — intervention group
Group type: COMPARATOR
Intervention: Standard fill voiding trial
Number of subjects: 174
Study 28086848 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents as Agents of Change (PAC©) intervention, a manualized, 16-session, group-based, health care professional-led intervention for parents
Number of subjects: 0
Study 25120110 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) supplementation (980 mg polyphenols daily)
Number of subjects: 16
Study 25120110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study 22101890 — intervention group
Group type: EXPERIMENTAL
Intervention: Female adult film performers
Number of subjects: 134
Study 22101890 — intervention group
Group type: COMPARATOR
Intervention: California women
Number of subjects: 134
Study 22221685 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 150
Study 22221685 — intervention group
Group type: COMPARATOR
Intervention: Face Mask (FM)
Number of subjects: 150
Study 19341577 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (GIC)
Number of subjects: 36
Study 19341577 — intervention group
Group type: COMPARATOR
Intervention: Auto‐polymerized resin‐based sealant (RBS)
Number of subjects: 36
Study 17213873 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure fell with hemodialysis (DeltaSBP <= -10 mm Hg)
Number of subjects: 443
Study 17213873 — intervention group
Group type: COMPARATOR
Intervention: Systolic blood pressure remained unchanged with hemodialysis (DeltaSBP -10 to 10 mm Hg)
Number of subjects: 443
Study 17213873 — intervention group
Group type: COMPARATOR
Intervention: Systolic blood pressure rose with hemodialysis (DeltaSBP >= 10 mm Hg)
Number of subjects: 443
Study 16827252 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 30 micrograms with hyperbaric bupivacaine 0.75% 2 ml (group B)
Number of subjects: 60
Study 16827252 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 10 micrograms with hyperbaric bupivacaine 0.75% 2 ml (group F)
Number of subjects: 60
Study 16827252 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine 0.75% 2 ml (group L control)
Number of subjects: 60
Study 12811695 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided intra-articular corticosteroid injection (low-dose injection)
Number of subjects: 89
Study 12811695 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs therapy
Number of subjects: 89
Study 12811695 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MRI follow-up
Number of subjects: 89
Study 9927354 — intervention group
Group type: EXPERIMENTAL
Intervention: Bradykinin (BK)
Number of subjects: 0
Study 9927354 — intervention group
Group type: EXPERIMENTAL
Intervention: Des‐Arg10‐lysylbradykinin
Number of subjects: 0
Study 7762835 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms and propofol 35 mg (FP)
Number of subjects: 12
Study 7762835 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms and midazolam 2 mg (FM)
Number of subjects: 12
Study 7762835 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms, midazolam 2 mg, and propofol 35 mg (FMP)
Number of subjects: 12
Study 7762835 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 56 g (orally administered)
Number of subjects: 12
Study 7762835 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 12
Study 2113967 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg DOPS
Number of subjects: 9
Study 2113967 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg DOPS
Number of subjects: 9
Study 2113967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 105656 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose insulin regimen (0.44 U/kg body weight loading dose half intramuscularly and half intravenously followed by 7 U/h intramuscularly)
Number of subjects: 30
Study 105656 — intervention group
Group type: COMPARATOR
Intervention: Constant infusion of 7 U/h in albumin-free saline (0.44 U/kg loading dose intravenously)
Number of subjects: 30
Study 105656 — intervention group
Group type: COMPARATOR
Intervention: Both groups (intervention and control)
Number of subjects: 30
Study 29890865 — intervention group
Group type: EXPERIMENTAL
Intervention: CFA plus recombinant FSH after day 8 (CFA-plus group)
Number of subjects: 268
Study 29890865 — intervention group
Group type: COMPARATOR
Intervention: CFA-only
Number of subjects: 268
Study 26880570 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation DES
Number of subjects: 1259